死亡率的好处和植入式心脏转换器-除器
1Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston 02114.
Circulation
|April 1, 1994
概括
自动植入式心脏转换器-除器 (ICD) 可以减少心脏突发死亡,但它们对整体存活率的影响不太确定. 根据患者的因素,生存益处有很大差异,这会影响未来的研究方向.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 临床研究 临床研究
背景情况:
- 自动植入式心脏转换器-除器 (ICD) 是对患有危及生命的腹腔动脉节律失常的患者的关键干预措施.
- 虽然在预防突发心脏病死亡方面有效,但ICDs提高患者整体存活率的程度仍然是正在进行的调查领域.
研究的目的:
- 审查关于ICDs对整体存活时间的影响现有数据.
- 分析患者特异性临床因素如何影响ICD植入所产生的死亡率益处.
- 讨论这些发现对未来临床研究和患者管理的影响.
主要方法:
- 审查现有的临床数据和关于自动植入式心脏转换器-除器的研究.
- 对子群体的分析,以确定影响生存效益的因素.
- 综合证据来评估ICDs的整体生存影响.
主要成果:
- 自动植入式心脏转换器-除器显著降低高风险患者的突然死亡率.
- ICDs所提供的整体生存益处并不统一,并且在不同患者群体之间存在很大差异.
- 其他临床因素在确定典型的ICD患者的生存结果方面发挥着重要作用.
结论:
- ICDs对死亡的好处是根据个体患者的特征和并发症调节的.
- 未来的研究应该专注于确定最有可能从ICD治疗中受益的患者亚群,以优化治疗策略.
- 了解这些调节因素对于完善患者选择和最大限度地提高ICD提供的生存优势至关重要.
相关概念视频
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation III: AED Use
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


